Forian Inc. Announces Fourth Quarter and Full Year 2023 Financial Results
March 28, 2024 16:06 ET
|
Forian Inc.
Full Year 2023 Revenue Grew 25% Full Year 2023 Adjusted EBITDA of $2.3MM NEWTOWN, PA, March 28, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Forian Inc. (Nasdaq: FORA), a provider of...
OKX publica su 17.ª proof of reserves (PoR) mensual, que muestra 22.1 mil millones de USD en activos primarios
March 28, 2024 04:00 ET
|
OKX
Dubái (Emiratos Árabes Unidos), March 28, 2024 (GLOBE NEWSWIRE) -- OKX, uno de los principales exchages de cripto y de las empresas tecnológicas de la Web3 más importantes a nivel mundial,...
OKX publica 17ª prova de reservas consecutiva, destacando USD 22.1 bilhões em ativos primários
March 28, 2024 04:00 ET
|
OKX
Dubai, Emirados Árabes Unidos, March 28, 2024 (GLOBE NEWSWIRE) -- A OKX, uma empresa líder global em tecnologia Web3 e corretora de criptomoedas, anunciou hoje a publicação do seu relatório de...
OKX تنشر تقرير إثبات الاحتياطيات السابع عشر على التوالي، والذي يشير إلى 22.1 مليار دولار أمريكي من الأصول الأساسية
March 28, 2024 04:00 ET
|
OKX
دبي, March 28, 2024 (GLOBE NEWSWIRE) -- الإمأعلنت OKX، الشركة العالمية الرائدة في مجال تكنولوجيا Web3 ومنصة تداول العملات الرقمية، اليوم عن إصدار أحدث تقرير لها عن إثبات الاحتياطيات، والذي يظهر حجم...
OKX Publishes 17th Consecutive Proof of Reserves, Highlighting USD22.1 Billion in Primary Assets
March 28, 2024 04:00 ET
|
OKX
DUBAI, United Arab Emirates, March 28, 2024 (GLOBE NEWSWIRE) -- OKX, a leading global Web3 technology company and crypto exchange, today announced the release of its latest Proof of Reserves (PoR)...
Vaccinex, Inc. Announces $1.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
March 27, 2024 08:30 ET
|
Vaccinex, Inc.
ROCHESTER, N.Y., March 27, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company pioneering a differentiated approach to...
Evaxion Announces Business Update and Full Year 2023 Financial Results
March 27, 2024 07:30 ET
|
Evaxion Biotech
Precision vaccine project initiated with the ambition to obtain Preclinical Proof-of-Concept by H2 2024. The novel concept entails AI-identification of a new class of cancer vaccine targets, named...
SANUWAVE Will Host a Conference Call on March 22, 2024 at 8:30 AM (ET) to Present the Q4 and FY2023 Financial Results
March 20, 2024 07:00 ET
|
SANUWAVE Health, Inc.
EDEN PRAIRIE, MN, March 20, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (the "Company" or "Sanuwave”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound...
Kane Biotech to Release Fourth Quarter and Full Year 2023 Financial Results on March 26, 2024 – Conference Call to Follow
March 19, 2024 16:10 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, March 19, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Fintech Market Size Projected To Grow To $882 Billion By 2030 as Advanced Technologies & Services Expand
March 19, 2024 08:30 ET
|
FN Media Group LLC
PALM BEACH, Fla., March 19, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - FinTech companies provide various financial technology services, tools, or solutions to other businesses (B2B)...